UNH stock jumps as UnitedHealth raises 2026 outlook

UNH stock surged after UnitedHealth Group crushed second-quarter estimates and raised its 2026 adjusted earnings outlook to $19.50–$20 per share, up from more than $18.25, as the insurer reined in costs, trimmed membership, and leaned on AI to stabilize margins. Shares jumped about 7% in premarket trading after the beat, according to CNBC.

Key Takeaways

• Adjusted EPS hit $6.38 versus the $4.90 Wall Street expected; revenue reached $112.03 billion versus $110.85 billion expected.
• Full-year 2026 adjusted earnings guidance rose to $19.50–$20 per share from more than $18.25, while revenue guidance stayed above $439 billion.
• UNH stock climbed about 7% premarket as margin work—smaller membership, exited contracts, and a $1.5 billion AI push—gained traction.
• The medical benefit ratio improved to 86.7% from 89.4% a year earlier, even as medical costs stayed elevated versus history.

For investors tracking wealth and mega-cap healthcare names, the print is a clear signal that UnitedHealth’s turnaround is showing up in earnings—not just rhetoric. More market and portfolio coverage lives in our Net Worth & Wealth section.

What did UnitedHealth report for Q2 2026?

Net income was $5.48 billion, or $6.04 per share, versus $3.41 billion, or $3.74 per share, a year earlier. On an adjusted basis—excluding items such as divestitures, restructuring, and reserve reductions for unprofitable contracts—earnings were $6.38 per share.

Revenue climbed to $112.03 billion from $111.62 billion in the prior-year quarter. Both UnitedHealthcare and Optum topped analysts’ sales estimates for the quarter, CNBC reported, citing StreetAccount.

Why did UNH stock react so strongly?

The beat was wide, and management hiked the profit outlook in the same breath. That combination matters for UNH stock because investors have been watching whether cost control and pricing can restore margins after years of elevated medical spending across the insurance industry.

CFO Wayne DeVeydt said the firm expects to “do better than” its maintained full-year revenue guidance of greater than $439 billion after the second-quarter beat. Still, he stressed medical costs remained “elevated over historical levels,” and that results reflected efforts to push down an already high base—not a full bend in the long-term cost trend.

How is UnitedHealth trying to rein in costs?

UnitedHealth is stabilizing margins by shrinking membership, exiting unprofitable contracts, and pouring $1.5 billion into artificial intelligence. DeVeydt said AI is speeding prior authorizations and improving payment accuracy by flagging fraud, waste, and abuse—while not deciding whether care is approved or denied.

UnitedHealthcare served 48.5 million people in the quarter, down 525,000 sequentially. Management forecasts roughly 500,000 fewer ACA exchange members and 1.1 million fewer Medicare Advantage members in 2026, as higher premiums and benefit changes pressure enrollment even as pricing helps keep revenue stable.

DeVeydt called the membership-versus-pricing trade-off “not a good thing for the system long term,” underscoring that affordability pressures remain a live risk even as earnings recover.